Anxiety and Depression Symptoms in Patients with Thyroid Cancer Isolated for 131I Treatment

甲狀腺癌症病人接受碘131隔離治療期間之焦慮憂鬱症狀

10.29478/TJP.200712.0008

蔡湘怡(Hsiang-Yi Tsai,)；楊延光(Yen-Kuang Yang)；游新(Eugene Hsin Yu)；歐弘毅(Horng-Yih Ou)

憂鬱 ； 焦慮 ； 甲狀腺癌 ； 放射線碘治療 ； anxiety ； depression ； thyroid cancer ； radionuclide therapy

台灣精神醫學

21卷4期（2007 / 12 / 01）

299 - 303

英文

癌症病人的治療過程中常出現焦慮與憂鬱。本研究的目的在探討甲狀腺癌症病人接受放射線碘隔離治療期間，焦慮與憂鬱的變化。本研究的對象為2000年6月份至2001年9月份期間，十三位甲狀腺癌症病人接受他們生平第一次的放射碘治療。他們在接受隔離之前，隔離之後24小時與48小時分別填寫情境焦慮量表與鄭氏憂鬱量表，來測量他們焦慮與憂鬱程度。研究結果顯示，在甲狀腺癌症病人接受放射線碘隔離治療期間，可能沒有明顯的焦慮與憂鬱變化。

Background: Depression and anxiety are highly prevalent among cancer patients. The aim of this study is to report the course of anxiety and depression in thyroid-cancer patients treated with [131Ⅰ] radionuclide under virtual isolation conditions. Methods: Thirteen adult patients were recruited for this study. All of these patients were hospitalized in the nuclear-medicine isolation facility for their first course of [131Ⅰ] radionuclide therapy within the period between June 2000 and September 2001 inclusively. A self-reported questionnaire packet, including the State- Trait Anxiety Inventory (STAI) and the 20-items Zung's Depression Scale (ZDS) was completed by all patients at baseline, and at 24 and 48 hours subsequent to isolation commencement. The STAI was utilized in order to measure anxiety. Result: Scores on the ZDS indicated levels of depressive symptoms. Conclusion: The results of the present study revealed that the process of isolation during radionuclide therapy for cancer patients may not necessarily alter an involved patient's psychological status.